News Quantified

IOVA – iovance biotherapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Iovance Biotherapeutics (NASDAQ:IOVA) had its "overweight" rating reaffirmed by analysts at Barclays PLC.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Down 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around? [Yahoo! Finance]

Iovance Biotherapeutics: Base-Case Q3 Report Keeps 'Show Me' Mode [Seeking Alpha]

Is Iovance Biotherapeutics (IOVA) Undervalued? A Fresh Look at Valuation After Recent Share Price Rebound [Yahoo! Finance]

16.7%

BEAT

-20.7%

MISS

-19.5%

BEAT

-19.5%

BEAT

Chardan Capital

Form 4 IOVANCE BIOTHERAPEUTICS, For: Dec 01 Filed by: GRAF FINCKENSTEIN FRIEDRICH

Form 4 IOVANCE BIOTHERAPEUTICS, For: Dec 01 Filed by: BILINSKY IGOR

Form 4 IOVANCE BIOTHERAPEUTICS, For: Dec 01 Filed by: Vogt Frederick G

Form 4 IOVANCE BIOTHERAPEUTICS, For: Dec 01 Filed by: Puri Raj K.

Form S-8 IOVANCE BIOTHERAPEUTICS,

Top News Gainers

5/15 Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs 36.1%

2/24 Form SC 13G/A IOVANCE BIOTHERAPEUTICS, Filed by: Avoro Capital Advisors LLC 27.4%

4/13 Iovance Biotherapeutics Announces H. Lee Moffitt Cancer Center to Present Lung Cancer Clinical Data at American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 17.5%

11/7 Iovance Biotherapeutics to Present at Upcoming Investor Conferences in November 15.8%

3/23 Novan up 27% on favorable safety profile of SB206, Covid-19 plan [Seeking Alpha] 11.6%

2/25 Iovance Biotherapeutics, Inc. (IOVA) CEO Maria Fardis on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 10.3%

1/8 Iovance Biotherapeutics Inc (NASDAQ: IOVA) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 8.4%

6/3 Iovance Biotherapeutics Inc (NASDAQ: IOVA) had its price target raised by analysts at HC Wainwright from $26.00 to $32.00. They now have a "buy" rating on the stock. 8.0%

10/2 Iovance Biotherapeutics Announces Four Abstracts to be Presented at the Upcoming 2019 SITC Annual Meeting 6.9%

11/4 Q3/2019 9/30/2019 EPS -0.400 ZacksConsensus -0.400 ActVsEst 0.000 - In-Line 6.6%

Top News Decliners

3/16 Iovance Biotherapeutics Inc (NASDAQ: IOVA) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -20.2%

1/12 BRIEF-Iovance Biotherapeutics Obtains License To Develop And Commercialize A Novel IL-2 Analog [Reuters] -14.5%

5/31 Iovance Biotherapeutics Inc (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $30.00 price target on the stock. -10.9%

4/28 Frazier Healthcare Partners Adds Experienced Capital Markets Executive to Life Sciences Team -10.0%

9/25 Form EFFECT IOVANCE BIOTHERAPEUTICS, -8.1%

8/1 Form 8-K IOVANCE BIOTHERAPEUTICS, For: Aug 01 -6.9%

6/11 Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors -5.3%

8/2 Iovance Biotherapeutics, Inc. (IOVA) Q2 2019 Earnings Call Transcript [The Motley Fool] -5.1%

4/27 Iovance Biotherapeutics Inc (NASDAQ: IOVA) had its price target raised by analysts at Chardan Capital from $36.00 to $44.00. They now have a "buy" rating on the stock. -4.5%

11/21 Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who are Primary Refractory to Anti-PD-1/L1 Therapy -4.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day